Australia markets open in 8 hours

Vicarious Surgical Inc. (RBOT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3608+0.0031 (+0.88%)
As of 11:57AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 62.97M
Enterprise value -6.57M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.75
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.22
52-week change 3-83.87%
S&P500 52-week change 324.69%
52-week high 32.3700
52-week low 30.2000
50-day moving average 30.3086
200-day moving average 30.4348

Share statistics

Avg vol (3-month) 3474.91k
Avg vol (10-day) 3418.05k
Shares outstanding 5156.42M
Implied shares outstanding 6176.04M
Float 857.33M
% held by insiders 131.75%
% held by institutions 140.48%
Shares short (15 May 2024) 45.21M
Short ratio (15 May 2024) 415.51
Short % of float (15 May 2024) 44.89%
Short % of shares outstanding (15 May 2024) 42.96%
Shares short (prior month 15 Apr 2024) 46.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-40.71%
Return on equity (ttm)-71.21%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -71.8M
Net income avi to common (ttm)-61.15M
Diluted EPS (ttm)-0.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)84.13M
Total cash per share (mrq)0.57
Total debt (mrq)14.59M
Total debt/equity (mrq)17.37%
Current ratio (mrq)17.16
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-58.19M
Levered free cash flow (ttm)-33.33M